|
| Entrez Id: |
26191 |
| Gene Symbol: |
PTPN22 |
PTPN22
|
0.500 |
GeneticVariation
|
group |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
|
| Entrez Id: |
7173 |
| Gene Symbol: |
TPO |
TPO
|
0.500 |
GeneticVariation
|
group |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
|
| Entrez Id: |
7038 |
| Gene Symbol: |
TG |
TG
|
0.500 |
GeneticVariation
|
group |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
|
| Entrez Id: |
26191 |
| Gene Symbol: |
PTPN22 |
PTPN22
|
0.500 |
GeneticVariation
|
group |
GWASCAT |
Risk for myasthenia gravis maps to a (151) Pro→Ala change in TNIP1 and to human leukocyte antigen-B*08.
|
23055271 |
2012 |
|
| Entrez Id: |
3559 |
| Gene Symbol: |
IL2RA |
IL2RA
|
0.200 |
GeneticVariation
|
group |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
|
| Entrez Id: |
7297 |
| Gene Symbol: |
TYK2 |
TYK2
|
0.200 |
GeneticVariation
|
group |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
|
| Entrez Id: |
6775 |
| Gene Symbol: |
STAT4 |
STAT4
|
0.200 |
GeneticVariation
|
group |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
|
| Entrez Id: |
3663 |
| Gene Symbol: |
IRF5 |
IRF5
|
0.200 |
GeneticVariation
|
group |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
|
| Entrez Id: |
5771 |
| Gene Symbol: |
PTPN2 |
PTPN2
|
0.200 |
GeneticVariation
|
group |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
|
| Entrez Id: |
10666 |
| Gene Symbol: |
CD226 |
CD226
|
0.200 |
GeneticVariation
|
group |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
|
| Entrez Id: |
3559 |
| Gene Symbol: |
IL2RA |
IL2RA
|
0.200 |
GeneticVariation
|
group |
GWASCAT |
Meta-analysis of shared genetic architecture across ten pediatric autoimmune diseases.
|
26301688 |
2015 |
|
| Entrez Id: |
9966 |
| Gene Symbol: |
TNFSF15 |
TNFSF15
|
0.200 |
GeneticVariation
|
group |
GWASCAT |
Meta-analysis of shared genetic architecture across ten pediatric autoimmune diseases.
|
26301688 |
2015 |
|
| Entrez Id: |
149233 |
| Gene Symbol: |
IL23R |
IL23R
|
0.200 |
GeneticVariation
|
group |
GWASCAT |
Meta-analysis of shared genetic architecture across ten pediatric autoimmune diseases.
|
26301688 |
2015 |
|
| Entrez Id: |
6775 |
| Gene Symbol: |
STAT4 |
STAT4
|
0.200 |
GeneticVariation
|
group |
GWASCAT |
Meta-analysis of genome-wide association studies in celiac disease and rheumatoid arthritis identifies fourteen non-HLA shared loci.
|
21383967 |
2011 |
|
| Entrez Id: |
5771 |
| Gene Symbol: |
PTPN2 |
PTPN2
|
0.200 |
GeneticVariation
|
group |
GWASCAT |
Meta-analysis of genome-wide association studies in celiac disease and rheumatoid arthritis identifies fourteen non-HLA shared loci.
|
21383967 |
2011 |
|
| Entrez Id: |
919 |
| Gene Symbol: |
CD247 |
CD247
|
0.190 |
GeneticVariation
|
group |
GWASCAT |
Meta-analysis of genome-wide association studies in celiac disease and rheumatoid arthritis identifies fourteen non-HLA shared loci.
|
21383967 |
2011 |
|
| Entrez Id: |
53347 |
| Gene Symbol: |
UBASH3A |
UBASH3A
|
0.180 |
GeneticVariation
|
group |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
|
| Entrez Id: |
60468 |
| Gene Symbol: |
BACH2 |
BACH2
|
0.180 |
GeneticVariation
|
group |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
|
| Entrez Id: |
53347 |
| Gene Symbol: |
UBASH3A |
UBASH3A
|
0.180 |
GeneticVariation
|
group |
GWASCAT |
Meta-analysis of genome-wide association studies in celiac disease and rheumatoid arthritis identifies fourteen non-HLA shared loci.
|
21383967 |
2011 |
|
| Entrez Id: |
64167 |
| Gene Symbol: |
ERAP2 |
ERAP2
|
0.170 |
GeneticVariation
|
group |
GWASCAT |
Meta-analysis of shared genetic architecture across ten pediatric autoimmune diseases.
|
26301688 |
2015 |
|
| Entrez Id: |
3716 |
| Gene Symbol: |
JAK1 |
JAK1
|
0.160 |
GeneticVariation
|
group |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
|
| Entrez Id: |
10318 |
| Gene Symbol: |
TNIP1 |
TNIP1
|
0.160 |
GeneticVariation
|
group |
GWASCAT |
Risk for myasthenia gravis maps to a (151) Pro→Ala change in TNIP1 and to human leukocyte antigen-B*08.
|
23055271 |
2012 |
|
| Entrez Id: |
814 |
| Gene Symbol: |
CAMK4 |
CAMK4
|
0.150 |
GeneticVariation
|
group |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
|
| Entrez Id: |
7332 |
| Gene Symbol: |
UBE2L3 |
UBE2L3
|
0.140 |
GeneticVariation
|
group |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
|
| Entrez Id: |
10019 |
| Gene Symbol: |
SH2B3 |
SH2B3
|
0.140 |
GeneticVariation
|
group |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |